Assessment of non ablative Radiofrequency in menopausal women with genitals and urinary syntoms

Assessment of non ablative Radiofrenquency in peri menopausal and posmenopausal women with Genitourinary Syndrome

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

REBEC

Registry ID

RBR-283y5bp

Enrollment

Registered

2026-03-16

Start date

2025-05-01

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female menopause and climacteric status

Interventions

In this randomized,two arms and double blinded trial, all eigthy selected patients will undergo vaginal material collection for the vaginal maturation index and will complete a questionnaire about gen

Eligibility

Sex/Gender

Female

Age

50 Years to 70 Years

Inclusion criteria

Inclusion criteria: Menopausal women (aged 50-70 years); dryness; dyspareunia; mild urinary incontinence.

Exclusion criteria

Exclusion criteria: Active vaginal infections;chronic vaginal infections;recent use of vaginal regenerative therapies; patients with contraindications to energy use;active cancer; active tuberculosis;pregnant women

Design outcomes

Primary

Measure	Time frame
Assess is radiofrequency therapy can improvement of the clinical symptoms of the urogenital syndrome	—

Secondary

Measure	Time frame
Assess the side effects of theRadiofrenquency therapies	—

Countries

Contacts

Public ContactJuliana Zimmermmann

Fundação José Bonifácio Lafayette de Andrada

cep@funjop.edu.br+55-32-33392955

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Apr 4, 2026